Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound traditional Chinese medicine for intervening hepatic fibrosis and preparation method and application thereof

A compound traditional Chinese medicine, liver fibrosis technology, applied in non-active ingredients medical preparations, active ingredients-containing medical preparations, digestive system and other directions, to achieve good resistance to liver fibrosis, improve bioavailability, reduce drug dosage Effect

Active Publication Date: 2021-09-17
NINGXIA MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is currently no drug that can effectively treat HF

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound traditional Chinese medicine for intervening hepatic fibrosis and preparation method and application thereof
  • Compound traditional Chinese medicine for intervening hepatic fibrosis and preparation method and application thereof
  • Compound traditional Chinese medicine for intervening hepatic fibrosis and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 10g lizard, 10g angelica root, 10g vinegar Bupleurum, 10g raw white peony root, 20g raw Atractylodes macrocephala, 10g poria cocos, 10g vinegar turtle shell, 20g salvia miltiorrhiza, red peony root 15g, licorice 10g, raw grain buds 20g, raw hawthorn 20g, Yuanhu 10g, antler gum 10g, saponins thorn 20g, ganoderma lucidum 20g, wolfberry 10g, bergamot 10g, ebony 10g.

Embodiment 2

[0042] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 15g lizard, 10g angelica root, 10g vinegar Bupleurum, 10g raw white peony root, 20g raw Atractylodes macrocephala, 10g poria cocos, 10g vinegar turtle shell, 20g salvia miltiorrhiza, red peony root 15g, licorice 10g, raw grain buds 20g, raw hawthorn 20g, Yuanhu 10g, antler gum 10g, saponins thorn 20g, ganoderma lucidum 20g, wolfberry 10g, bergamot 10g, ebony 20g.

Embodiment 3

[0044] A compound traditional Chinese medicine for intervening liver fibrosis, which is composed of the following raw materials: 20g lizard, 20g angelica root, 15g vinegar Bupleurum, 20g raw white peony root, 30g raw Atractylodes macrocephala, 15g poria cocos, 15g vinegar turtle shell, 30g salvia miltiorrhiza, red peony root 30g, licorice 20g, raw grain buds 30g, raw hawthorn 30g, Yuanhu 25g, antler gum 20g, saponins thorn 30g, ganoderma lucidum 30g, wolfberry 20g, bergamot 20g, ebony 20g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of traditional Chinese medicines, and particularly relates to a compound traditional Chinese medicine for intervening hepatic fibrosis and a preparation method thereof. The compound traditional Chinese medicine consists of the following raw materials in parts by weight: 10 to 30 parts of lizard, 10 to 30 parts of radix angelicae sinensis, 10 to 20 parts of vinegar-processed radix bupleuri, 10 to 30 parts of raw radix paeoniae alba, 20 to 50 parts of raw rhizoma atractylodis macrocephalae, 10 to 30 parts of poria cocos, 10 to 30 parts of vinegar-processed turtle shell, 20 to 50 parts of radix salviae miltiorrhizae, 15 to 45 parts of radix paeoniae rubra, 10 to 30 parts of liquorice root, 20 to 50 parts of raw rice sprout, 20 to 40 parts of raw fructus crataegi, 10 to 30 parts of rhizoma corydalis, 10 to 30 parts of deer-horn glue, 20 to 50 parts of spina gleditsiae, 20 to 50 parts of lucid ganoderma, 10 to 30 parts of fructus lycii, 10 to 30 parts of fingered citron, and 10-30 parts of fructus mume. The compound preparation has a remarkable curative effect on hepatic fibrosis caused by deficiency of liver blood and stasis of veins.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a compound traditional Chinese medicine for intervening liver fibrosis, a preparation method and application thereof. Background technique [0002] Hepatic fibrosis (hepatic fibrosis, HF) is a pathological change that exists in most chronic liver diseases. changes and affect their normal physiological functions. HA, LN, PC-Ⅲ and Ⅳ-C are all important components of ECM. When liver fibrosis occurs, the content of HA, LN, PC-Ⅲ and Ⅳ-C in serum will increase correspondingly. The clinical detection of liver fibrosis can also express the severity of liver fibrosis. There is currently a lack of a drug that can effectively treat HF. Contents of the invention [0003] The object of the present invention is to provide a compound traditional Chinese medicine for intervening liver fibrosis and a preparation method thereof. [0004] In order to achieve the above-me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61K9/06A61K47/36A61P1/16A61K35/583A61K35/586A61K35/32
CPCA61K35/583A61K36/232A61K36/233A61K36/71A61K36/65A61K36/284A61K36/076A61K35/586A61K36/537A61K36/484A61K36/899A61K36/734A61K36/66A61K35/32A61K36/483A61K36/074A61K36/815A61K36/752A61K36/736A61K9/06A61K9/0053A61K47/36A61P1/16A61K2300/00
Inventor 景燕燕李卫强
Owner NINGXIA MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com